← board
LSBWF
distress 3/10 · well-funded / low risk$0.01+1567%today0% from 52w high
Revenue
$86M
Liquidity
$15M
Runway
0.9 yrs
Shares 1y
-78%
Price & events
+1566.7% over 6M
CatalystRating changeDilutionFinancingdashed = today
+1566.7%
1D
+1566.7%
1W
+1566.7%
1M
—
3M
—
6M
—
1Y
—
2Y
—
5Y
+1566.7%
All
Overview
- Market Cap
- $103.83K
- Enterprise Value
- $-11.60M
- Volume
- 97.50K
- 52 Week Range
- $0.00 – $0.01
- Total Shares
- 20.77M
- Float Shares
- 41.21M
- RVOL
- 1.94x
- Beta
- 1.09
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 0
- No catalyst news yet.
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 20,766,531 · 0 offerings/1y · 0 PIPEs
- none
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- none
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.